JAGX
NASDAQ · Pharmaceuticals
Jaguar Health Inc
$0.97
+0.03 (+3.11%)
Open$0.98
Previous Close$0.94
Day High$0.98
Day Low$0.94
52W High$92.75
52W Low—
Volume—
Avg Volume97.4K
Market Cap4.75M
P/E Ratio—
EPS$-713.94
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,845.3% upside
Current
$0.97
$0.97
Target
$47.90
$47.90
$35.39
$47.90 avg
$54.68
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 847.32M | 858.13M | 728.2K |
| Net Income | -3,933,246,142 | -3,585,093,708 | 171.9K |
| Profit Margin | -464.2% | -441.0% | 23.6% |
| EBITDA | -3,370,870,381 | -3,243,191,069 | 249.9K |
| Free Cash Flow | — | — | 132.1K |
| Rev Growth | -1.3% | -1.3% | -5.9% |
| Debt/Equity | 3.64 | 3.64 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |